Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.

NCT06364176 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Losartan
DRUG: Placebo

Sponsor

University of Kansas Medical Center